ZFYVE21
- 1 lab in 1 country
- Funders: American Federation for Aging Research and 7 more
- 3 of 3 findings with company ties
- Humans1
- Animals1
Effects
3Glomerular EC injury
downin mice1
1 study
Glomerular EC injury
downin mice1
ZFYVE21 protects against glomerular EC injury in mice.
“Kidneys from Zfyve21 EC-/- mice showed interstitial edema and glomerular EC injury.”
Animalsknockoutkidney
Kidney internationalMay 24, 2024
NOS3
upin mice1
1 study
NOS3
upin mice1
ZFYVE21 activates NOS3 in mice.
“These knockout mice developed accelerated aging phenotypes including reduced endothelial nitric oxide (ENOS) activity, failure to thrive, and kidney insufficiency.”
Animalsknockoutkidney
Kidney internationalMay 24, 2024
Kidney insufficiency
downin mice1
1 study
Kidney insufficiency
downin mice1
ZFYVE21 protects against kidney insufficiency in mice.
“These knockout mice developed accelerated aging phenotypes including reduced endothelial nitric oxide (ENOS) activity, failure to thrive, and kidney insufficiency.”
Animalsknockoutkidney
Kidney internationalMay 24, 2024
Latest
1 in 12 monthsAHA Scientific Sessions 2025 Abstract
Epigenetic Architecture of Abdominal Aortic Aneurysm and Its Augmented Risk in Smokers: Insights from Methylome-Genome Integration
Cohort study of 40,492 peopleMechanisms
Kidney International
ZFYVE21 promotes endothelial nitric oxide signaling and vascular barrier function in the kidney during aging
Experiments in miceNitric oxide–cGMP signalling